Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2009Clinical Cancer Research

The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDavide RossiOspedale di Santo SpiritoMCMichaela CerriUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”CDClara DeambrogiUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rossi et al. (2009) studied this question.

synapsesocial.com/papers/6a11ca6eed9c06332dfd37a3https://doi.org/10.1158/1078-0432.ccr-08-1630
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E29972007 · 354 citations
  2. 2Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia2006 · 250 citations
  3. 3V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia2002 · 789 citations
  4. 4p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis1997 · 99 citations
  5. 5Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and VH Mutation Status in Chronic Lymphocytic Leukemia2006 · 196 citations